Crossmark

Elevated doublecortin-like kinase 1 serum levels revert to baseline after therapy in early stage esophageal adenocarcinoma

Crossref DOI link: https://doi.org/10.1186/s40364-019-0157-z

Published Online: 2019-03-08

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Christman, Emily M.

Chandrakesan, Parthasarathy

Weygant, Nathaniel

Maple, John T.

Tierney, William M.

Vega, Kenneth J.

Houchen, Courtney W.
License Information

Text and Data Mining valid from 2019-03-08
More Information

Article History

Received: 12 December 2018

Accepted: 27 February 2019

First Online: 8 March 2019

Ethics approval and consent to participate

: All patients provided informed consent and samples were deidentified. The University of Oklahoma Health Sciences Center Institutional Review Board approved the study.

: Not applicable.

: NW and CWH have ownership interests in COARE Holdings Inc.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.